Ryan Fischesser's most recent trade in Caribou Biosciences Inc was a trade of 25,000 Common Stock done . Disclosure was reported to the exchange on Nov. 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2024 | 25,000 | 118,854 | - | 0 | Common Stock | |
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | Sale of securities on an exchange or to another person at price $ 10.80 per share. | 06 Oct 2022 | 10,000 | 110,366 | - | 10.8 | 107,958 | Common Stock |
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2022 | 2,839 | 1,704 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.11 per share. | 06 Oct 2022 | 2,839 | 116,044 | - | 4.1 | 11,668 | Common Stock |
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.69 per share. | 06 Oct 2022 | 2,839 | 113,205 | - | 2.7 | 7,637 | Common Stock |
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2022 | 2,839 | 15,337 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2022 | 4,848 | 120,366 | - | 0 | Common Stock | |
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 1,138 | 19,314 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.11 per share. | 15 Mar 2022 | 1,138 | 113,244 | - | 4.1 | 4,677 | Common Stock |
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 1,136 | 5,679 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.69 per share. | 15 Mar 2022 | 1,136 | 112,106 | - | 2.7 | 3,056 | Common Stock |
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | 11 Jan 2022 | 6,818 | 20,452 | - | - | Option to purchase Common Stock | ||
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | Purchase of securities on an exchange or from another person at price $ 4.11 per share. | 11 Jan 2022 | 6,818 | 109,082 | - | 4.1 | 28,022 | Common Stock |
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | Purchase of securities on an exchange or from another person at price $ 2.69 per share. | 11 Jan 2022 | 569 | 102,264 | - | 2.7 | 1,531 | Common Stock |
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | 11 Jan 2022 | 569 | 6,815 | - | - | Option to purchase Common Stock | ||
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2021 | 40,000 | 40,000 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | 20 Dec 2021 | 1,136 | 7,384 | - | - | Option to purchase Common Stock | ||
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | Purchase of securities on an exchange or from another person at price $ 2.69 per share. | 20 Dec 2021 | 1,136 | 101,695 | - | 2.7 | 3,056 | Common Stock |
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | Purchase of securities on an exchange or from another person at price $ 2.69 per share. | 11 Oct 2021 | 1,746 | 100,559 | - | 2.7 | 4,697 | Common Stock |
| Caribou Biosciences Inc | Ryan Fischesser | VP of Finance and Controller | 11 Oct 2021 | 1,746 | 8,520 | - | - | Option to purchase Common Stock |